KIDNEY DISEASE, CHRONIC
Clinical trials for KIDNEY DISEASE, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new KIDNEY DISEASE, CHRONIC trials appear
Sign up with your email to follow new studies for KIDNEY DISEASE, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare kidney disease in early trial
Disease control CompletedThis study tested a new medicine, BI 764198, in 67 adults with a kidney disease called FSGS. The goal was to see if the drug could reduce protein in the urine, a sign of kidney damage. Participants took either the drug or a placebo daily for 12 weeks. The results help researchers…
Matched conditions: KIDNEY DISEASE, CHRONIC
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 17, 2026 08:51 UTC
-
New training slashes dialysis infections
Disease control CompletedThis study tested a new training package called TEACH-PD for patients starting peritoneal dialysis and their nurses. The goal was to see if better training could lower the risk of infections like peritonitis. Over 1,400 patients from multiple countries took part, and researchers …
Matched conditions: KIDNEY DISEASE, CHRONIC
Phase: NA • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
JARDIANCE under watch: new study tracks kidney drug safety in korean patients
Disease control CompletedThis study looked at how safe and effective JARDIANCE (empagliflozin) is for Korean adults with chronic kidney disease (CKD) in everyday medical practice. Researchers monitored 299 patients for side effects and checked changes in a key kidney health marker (urine albumin-creatini…
Matched conditions: KIDNEY DISEASE, CHRONIC
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 12, 2026 13:44 UTC
-
New device lets kidney transplant patients check their health at home
Diagnosis CompletedThis study tested a small, portable device that measures creatinine (a kidney health marker) in the blood. 100 kidney transplant patients used the device at clinic visits, and 30 also used it at home. The goal was to see if the device is as accurate as standard lab tests and to l…
Matched conditions: KIDNEY DISEASE, CHRONIC
Phase: NA • Sponsor: Royal Free Hospital NHS Foundation Trust • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC
-
CBD-Tacrolimus interaction study completed: key dosing insights revealed
Knowledge-focused CompletedThis study looked at how cannabidiol (CBD) interacts with tacrolimus, a drug used to prevent organ rejection in transplant patients. Researchers measured drug levels in 57 healthy adults and those with chronic kidney disease to understand how genetics and CBD affect dosing. The g…
Matched conditions: KIDNEY DISEASE, CHRONIC
Phase: PHASE1 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 17, 2026 08:47 UTC